Japan Neurovascular Devices Market

Market Overview:

Japan neurovascular devices market size reached USD 183.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 349.4 Million by 2033, exhibiting a growth rate (CAGR) of 7.03% during 2025-2033. Technological progress, a growing incidence of neurovascular conditions, and an aging population that favors less invasive treatments represent some of the key factors driving the market.

Neurovascular devices are medical instruments specifically designed for the diagnosis and treatment of disorders affecting the blood vessels and nervous system within the brain and spinal cord. They are meticulously manufactured using advanced materials and precision engineering methods to ensure their safety and effectiveness. These devices offer substantial benefits by facilitating minimally invasive procedures, thereby reducing patient discomfort, hospitalization durations, and complications. Neurovascular devices have a wide range of applications in addressing various conditions, including aneurysms, arteriovenous malformations, and ischemic strokes. The categories of neurovascular devices encompass stents, embolic coils, flow diverters, and catheters. Stents provide support to maintain blood vessel integrity, while embolic coils assist in blocking blood flow to treat aneurysms. Flow diverters are employed to redirect blood flow away from weakened vessel areas, and catheters enable the targeted delivery of treatments to affected regions.

Japan Neurovascular Devices Market Trends:

The Japan market for neurovascular devices is significantly influenced by the rising incidence of neurovascular disorders, particularly among the elderly population. As life expectancy continues to increase, so does the prevalence of conditions like ischemic strokes and cerebral aneurysms, necessitating advanced medical interventions. Concurrently, technological advancements in neurovascular devices are reshaping the landscape of interventional neurology. Innovations such as flow-diverting stents and detachable coils are augmenting the effectiveness and safety of neurovascular procedures, garnering interest from healthcare providers and patients alike. Furthermore, the growing recognition of the importance of early diagnosis and treatment for neurovascular disorders is driving market expansion. Besides this, public health campaigns and initiatives centered on stroke awareness and the benefits of timely intervention are boosting patient referrals and treatment rates. Additionally, favorable reimbursement policies and the development of healthcare infrastructure in emerging markets are widening access to neurovascular interventions, propelling market growth on a wide scale. Other factors, including extensive research and development (R&D) efforts undertaken by key industry players and an increasing level of awareness among the general populace, are anticipated to propel the regional market in the coming years.

Japan Neurovascular Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product, application, and end user.

Product Insights:

• Cerebral Embolization and Aneurysm Coiling Devices         
  • Embolic Coils
  • Flow Diverters
  • Liquid Embolic Agents
• Cerebral Angioplasty and Stenting Systems 
  • Carotid Artery Stents
  • Embolic Protection Devices
• Neurothrombectomy Devices           
  • Clot Retrieval Devices
  • Suction Devices
  • Vascular Snares
• Support Devices        
  • Micro Catheters
  • Micro Guidewires

The report has provided a detailed breakup and analysis of the market based on the product. This includes cerebral embolization and aneurysm coiling devices (embolic coils, flow diverters and liquid embolic agents), cerebral angioplasty and stenting systems (carotid artery stents and embolic protection devices), neurothrombectomy devices (clot retrieval devices, suction devices, and vascular snares), and support devices (micro catheters and micro guidewires).

Application Insights:

• Ischemic Stroke
• Aneurysm
• Arteriovenous Malformation and Fistulas (AVM)
• Stenosis
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes ischemic stroke, aneurysm, arteriovenous malformation and fistulas (AVM), stenosis, and others.

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, clinics, and others.

Regional Insights:

• Kanto Region
• Kansai/Kinki Region
• Central/ Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Japan Neurovascular Devices News:

• July 2025: Johnson & Johnson MedTech revealed the introduction of the VARIPULSE™ Platform in the Asia-Pacific region. The platform facilitates catheter ablation procedures for atrial fibrillation (AFib), characterized by an irregular and frequently rapid heartbeat due to additional, uncoordinated electrical signals in the atria. AFib is linked to structural modifications in the heart from underlying conditions and lifestyle influences. It greatly elevates the risk of stroke, heart failure, and mortality.
• May 2025: MicroPort® CRM, an innovative leader in Cardiac Rhythm Management based in France, proudly reveals the inaugural implantation in Japan as part of its global post-market clinical study, PIANO. The PIANO study aims to evaluate the safety and efficacy of MicroPort CRM's pacemakers and defibrillators that are available for commercial use, such as Implantable.
• December 2024: Kaneka Corporation purchased 96.8% of the shares of EndoStream Medical Ltd, an Israeli company specializing in medical equipment, on December 23, 2024. Through the integration of Kaneka's manufacturing capabilities and ESM's technology, we will collaboratively create innovative medical devices focused primarily on cerebrovascular treatments, alongside the Nautilus™ device for aneurysm treatment that is currently being developed. Our goal is to reach sales exceeding 20 billion yen by the year 2030.
• September 2024: Toro Neurovascular, a forward-thinking medical device firm, is thrilled to declare the successful treatment of its first patient with the Toro 88 SuperBore Aspiration Catheter in a first-in-man clinical investigation. The operation, conducted by renowned neurosurgeon Nobuyuki Sakai, MD, DMSc., along with his team at Shimizu Hospital in Japan, signifies an important advancement in Toro’s goal to revolutionize stroke care with innovative technology.
• July 2024: MicroVention, Inc., a worldwide neurovascular entity and a wholly owned subsidiary of Terumo Corporation, revealed the publication of the SOFIA™ Aspiration System as first-line Technique (SOFAST): A prospective, multicenter investigation to evaluate the effectiveness and safety of the 6 French SOFIA™ Flow Plus Aspiration Catheter for endovascular stroke thrombectomy, recently featured in the Journal of NeuroInterventional Surgery (JNIS). Established in 1997, MicroVention creates and sells medical devices that facilitate or greatly enhance the treatment of cerebrovascular conditions. In 2006, the prominent global medical device firm Terumo Corporation, based in Tokyo, Japan, purchased MicroVention to add to their group of Companies.
• January 2024: Kaneka has entered into an exclusive distribution contract with the Israeli medical device firm, Rapid Medical Ltd., for a neurovascular device to retrieve blood clots (stent retriever*1), TIGERTRIEVER ™, in Japan. The stent retrievers available in Japan are self-expanding, and their expanded stents can potentially harm vessel walls while retrieving blood clots. TIGERTRIEVER™, with which we have established the contract, includes a distinct mechanism that enables the stent to be opened and closed, facilitating the entrapment and retrieval of neurovascular blood clots while reducing the stress on blood vessels. This is the initial launch of a stent retriever with this characteristic in Japan.

Japan Neurovascular Devices Market Report Coverage:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Japan neurovascular devices market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Japan neurovascular devices market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Japan neurovascular devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.